Back to News
Market Impact: 0.15
ImmunoScape Appoints Peter Olagunju as Chief Executive Officer
Source: Business Wire
Healthcare & BiotechManagement & Governance
ImmunoScape appointed Peter Olagunju as CEO as it prepares to move its Seed and Boost platform into clinical development. The leadership change supports the biotech company's transition toward a key clinical-stage milestone, though no financial terms, trial timing, or efficacy data were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Street Calls of The Week
- Binance CFO exits days after catastrophic $6 billion crypto hack
- Coffee giant Dutch Bros made all of its executives, including the CEO, do a two-week bootcamp where they learned how to pour drinks and run stores
- Binance CFO is leaving to ‘pursue a new venture’ after $6.3 billion hack
- Poland’s Domanski blames presidential vetoes as S&P cuts outlook to negative
- Berkshire Makes Record $9.6 Billion Buyback